Neotech Revenue and Competitors
Estimated Revenue & Valuation
- Neotech's estimated annual revenue is currently $28.6M per year.
- Neotech's estimated revenue per employee is $159,500
Employee Data
- Neotech has 179 Employees.
- Neotech grew their employee count by 14% last year.
Neotech Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $26.5M | 108 | -4% | N/A | N/A |
What Is Neotech?
Neotech Development is an international software development company with several offices around the world (Tallinn, Estonia | Riga, Latvia | Florida, USA | Minsk, Belarus). We are a team of highly skilled, engaged and passionate about software development IT professionals. Our goal is creating a software product of upmost quality by using cutting-edge technologies and solutions. We care about our colleagues, therefore, we provide them with all necessary equipment and benefits taking into consideration individual requests. If you are looking for the great colleagues, interesting development projects, great office space with amazing sunset views, great coffee and fridge full of snacks, you're looking for Neotech Development!
keywords:N/A
N/A
Total Funding
179
Number of Employees
$28.6M
Revenue (est)
14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Neotech News
Hollister, Neotech, Smiths, Dale, Avacare Medical, Laerdal Medical, Medline, CooperSurgical, Flexicare Medical, Ambu.
Sylvan, AccuVein, nice Neotech Medical Systems, AVI Healthcare, BOB Technika Swiatlowodowa, Evena Medical, InSono, Stihler Electronic.
Neuhaus Neotec previews many new developments for the coffee industry in 2022, including the release of the German manufacturer's new drum...
Other Companies in Tallinn
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $26.6M | 186 | 24% | N/A |
#2 | $26.9M | 188 | -33% | N/A |
#3 | $33.2M | 208 | -26% | N/A |
#4 | $32.9M | 230 | 9% | N/A |
#5 | $67.4M | 250 | 8% | N/A |